Theravance Biopharma (TBPH) Inventory (2013 - 2018)

Theravance Biopharma (TBPH) has 6 years of Inventory data on file, last reported at $17.9 million in Q3 2018.

• On a quarterly basis, Inventory rose 17.47% year-over-year to $17.9 million in Q3 2018; TTM through Sep 2018 was $17.9 million, a 17.47% increase from a year earlier, with the FY2017 full-year figure at $16.8 million, up 37.73% from the prior year.
• Inventory for Q3 2018 stood at $17.9 million, roughly flat from $17.9 million in the prior quarter.
• Over the last five years, Inventory for TBPH reached as high as $17.9 million in Q3 2018 and fell as low as $9.4 million in Q1 2016.
• Historically, Inventory has averaged $13.4 million across 5 years, with a median of $12.5 million in 2014.
• Across the five-year window, Inventory slipped 23.76% in 2016 and soared 47.67% in 2018, its largest moves.
• Year by year, Inventory stood at $12.5 million in 2014, then fell by 20.25% to $10.0 million in 2015, then grew by 22.14% to $12.2 million in 2016, then surged by 37.73% to $16.8 million in 2017, then climbed by 6.49% to $17.9 million in 2018.
• Per Business Quant data, the three most recent Inventory figures were $17.9 million in Q3 2018, $17.9 million in Q2 2018, and $17.2 million in Q1 2018.